Cell Signaling Peptides: Structural Diversity and Functional Attributes
Title: Cell Signaling Peptides: Structural Diversity and Functional Attributes Abstract: Cell signaling peptides exhibit structural diversity (linear, cyclic, branched) driving functional specificity in therapeutics and cosmetics. The global peptide market, valued at $40 billion (2024), grows at 8.5% CAGR, driven by targeted therapies. Brand comparison reveals Novosom’s high-purity (>98%) vs. Peptron’s cost-efficiency. Key advantages include high specificity and low toxicity; limitations involve poor stability and high production costs. Product parameters (purity, sequence length, endotoxin levels) dictate efficacy. Applications span oncology, metabolic disorders, and anti-aging. Industry trends favor GMP-certified factories and cold-chain logistics. Selection criteria prioritize validated certificates (e.g., FDA, COA) and batch consistency.